Gemcitabine
Auto-discovered · not yet curatedgemcitabine
Educational only, not medical advice. OncoForge makes no claim that Gemcitabine treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.
Simple Summary
Auto-discovered from 1 recent study; not yet curated.
Research
No published studies for Gemcitabine yet
New studies appear here once they’ve been reviewed. Browse all studies.
Trials studying Gemcitabine
503 recruiting on ClinicalTrials.gov. Recruiting is not the same as proven. Search ClinicalTrials.gov →
- Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerNCT06081959Phase 3Recruiting
- Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)NCT05431270Phase 1 / Phase 2Recruiting
- Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront SurgeryNCT06391892Phase 3Recruiting
- Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic CancerNCT06783140Phase 2 / Phase 3Recruiting
- Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)NCT06712420Phase 3Recruiting
Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.